Who are Intraduodenal denatonium benzoate's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Intragastric denatonium benzoate, Intraduodenal quinine hydrochloride.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/intraduodenal-denatonium-benzoate.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

Intraduodenal denatonium benzoate — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Intraduodenal denatonium benzoate (Intraduodenal denatonium benzoate) competitive landscape: 2 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Bitter taste receptor agonist. Area: Gastroenterology.

marketed Bitter taste receptor agonist Bitter taste receptors (T2Rs), particularly TAS2R family members Gastroenterology Small molecule Live · refreshed every 30 min

Target snapshot

Intraduodenal denatonium benzoate (Intraduodenal denatonium benzoate) — Universitaire Ziekenhuizen KU Leuven. Denatonium benzoate is a bitter-tasting compound administered intraduodenally that triggers taste receptors to elicit a protective reflex and modify gastrointestinal function.

Comparator set (2 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
Intraduodenal denatonium benzoate TARGET	Intraduodenal denatonium benzoate	Universitaire Ziekenhuizen KU Leuven	marketed	Bitter taste receptor agonist	Bitter taste receptors (T2Rs), particularly TAS2R family members
Intragastric denatonium benzoate	Intragastric denatonium benzoate	Universitaire Ziekenhuizen KU Leuven	marketed	Bitter taste receptor agonist / Aversive agent	Bitter taste receptors (T2R family)
Intraduodenal quinine hydrochloride	Intraduodenal quinine hydrochloride	Universitaire Ziekenhuizen KU Leuven	marketed	Bitter taste receptor agonist	TAS2R (bitter taste receptors)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Bitter taste receptor agonist class)

Universitaire Ziekenhuizen KU Leuven · 2 drugs in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Intraduodenal denatonium benzoate — Competitive Intelligence Brief. https://druglandscape.com/ci/intraduodenal-denatonium-benzoate. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab